Breast tumors were first classified based on their hormone receptor status (estrogen (ER) and/or progesterone receptors (PR)), whether they overexpressed HER2, or did not express either ER, PR, or HER2, termed triple-negative breast cancer (TNBC) [3]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.